GENE ONLINE|News &
Opinion
Blog

2025-11-28|

Biancaea sappan Extract-Coated Zinc Nanoparticles Studied for Textile Dye Degradation

by GOAI
Share To

Researchers have investigated the use of Biancaea sappan extract-coated zinc nanoparticles for the degradation of textile dyes, according to a recent study published in *Scientific Reports*. The study focused on addressing environmental concerns associated with dye pollution by exploring eco-friendly and efficient methods for breaking down harmful dye compounds. The findings highlight the potential application of plant-based materials combined with nanotechnology to mitigate industrial waste.

The research team synthesized zinc nanoparticles using an extract from Biancaea sappan, a plant known for its medicinal properties. They tested these nanoparticles on various textile dyes under controlled conditions. Results showed significant degradation of the dyes, suggesting that this method could serve as an effective solution for reducing dye pollutants in wastewater. The study emphasized the importance of sustainable approaches in tackling industrial pollution and demonstrated how natural resources can be integrated into advanced technological applications. Further analysis is required to evaluate scalability and long-term environmental impacts.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: November 28, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
Taiwan Healthcare Expo Opens With €200 Million Czech Deal as Global Buyers Flock to Taipei
2025-12-07
LATEST
Taiwan Healthcare Expo Opens With €200 Million Czech Deal as Global Buyers Flock to Taipei
2025-12-07
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
How AWS Cloud Is Transforming Global Smart Healthcare and Trusted Research Environments
2025-12-03
MedTex 2025: Taiwan as Gateway for AI-Driven Medical Innovation and Global Capital
2025-12-03
FDA CBER Director Vinay Prasad Issues November 2025 Memo Addressing Vaccine Development and Regulatory Challenges
2025-12-03
FDA to Review 16 Drug Applications Including 8 New Molecular Entities by Year-End
2025-12-03
Stephen Durso Named CEO of Altimmune Inc. as Vipin Garg Steps Down
2025-12-03
EVENT
2025-12-06
The 67th ASH Annual Meeting and Exposition
Orlando, Florida, USA
Scroll to Top